1. Dudczak R, Kletter K, Bailer H, Kokoschka E, PohlMarkl H. Immunszintigraphie mit einem Technetium-99-mmarkierten monoklonalen Antikörper bei Patienten mit Melanom. Wien Klin Wochenschr 1987; 99: 232–239.
2. Köhler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specifity. Nature 1975; 256: 495–497.
3. Buraggi GL, Callegaro L, Mariani G, Turrin A, Cascinelli N, Attili A, Bombardieri E, Terno G, Plassio G, Dovis M et al. Imaging with 131I-labeled monoclonal antibodies to a high-molecular-weight melanoma-associated antigen in patients with melanoma: efficacy of whole immunoglobulin and its F(ab’)2 fragments. Cancer Res 1985; 45: 3378–3387.
4. Murray JL, Rosenblum MG, Sobol RE, Bartholomew RM, Plager CE, Haynie TP, Jahns MF, Glenn HJ, Lamki L, Benjamin RS et al. Radioimmunoimaging in malignant melanoma with 111In-labeled monoclonal antibody 96.5. Cancer Res 1985; 45: 2376–2381.
5. Taylor A Jr, Milton W, Eyre HP, Christian P, Wu F, Hagan P, Alazraki N, Datz FL, Unger M. Radioimmunodetection of human melanoma with indium-111labeled monoclonal antibody. J Nucl Med 1988; 29: 329–337.